✦ LIBER ✦

Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease

✍ Scribed by Henslee-Downey, J; Kernan, N; Yanovich, S; Weisdorf, D; de Lissovoy, G; Hurd, D; Carter, S; Beatty, P; Ewell, M

Book ID: 110014713
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 182 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective depletion of marrow-T cytotoxi

Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation

✍ D. Maraninchi; C. Mawas; D. Guyotat; J. Reiffers; J. P. Vernant; N. Gratecos; J. 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 418 KB

In vitro depletion of mature pan-T lymphocytes has been widely and successfully used to prevent acute graft-versus-host disease (GVHD) after allogeneic bone-marrow transplantation (BMT). However, this procedure has been associated with a high incidence of graft failure and leukemic relapse. In this

Antithymocyte globulin for the preventio

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

✍ Basara, N; Baurmann, H; Kolbe, K; Yaman, A; Labopin, M; Burchardt, A; Huber, C; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB

Expression of T cell activation antigen

Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation

✍ van Esser, J W J; Bolhuis, R L H; Cornelissen, J J; Gadisseur, A P A; Gratama, J 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 59 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets